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Toward understanding topographically specific branching of retinal axons in their target area, we have studied the interaction between
neurotrophin receptors and members of the Eph family. TrkB and its ligand BDNF are uniformly expressed in the retina and tectum,
respectively, andexert abranch-promoting activity,whereasEphAsandephrinAsare expressed ingradients in retina and tectumandcan
mediate a suppression of axonal branching.Wehave identified anovel cis interactionbetween ephrinA5 andTrkBon retinal ganglion cell
axons. TrkB interactswith ephrinA5 via its second cysteine-rich domain (CC2), which is necessary and sufficient for binding to ephrinA5.
Their functional interaction is twofold: ephrinA5 augments BDNF-promoted retinal axon branching in the absence of its activator
EphA7–Fc,whereas EphA7–Fc application abolishes branching in a local and concentration-dependentmanner. The importance of TrkB
in this process is shown by the fact that overexpression of an isolated TrkB–CC2 domain interfering with the ephrinA/TrkB interaction
abolishes this regulatory interplay, whereas knockdown of TrkB via RNA interference diminishes the ephrinA5-evoked increase in
branching. The ephrinA/Trk interaction is neurotrophin induced and specifically augments the PI-3 kinase/Akt pathway generally
known to be involved in the promotion of branching. In addition, ephrinAs/TrkBmodulate axon branching and also synapse formation
of hippocampal neurons. Our findings uncover molecular mechanisms of how spatially restricted axon branching can be achieved by
linking globally expressed branch-promoting with differentially expressed branch-suppressing activities. In addition, our data suggest
that growth factors and the EphA–ephrinA system interact in a way that affects axon branching and synapse development.
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Introduction
During development of the nervous system, precisely ordered
neuronal connections are formed in a gradual, stepwise process.
In the chick and mouse retinotectal/collicular projection, for ex-
ample, retinal ganglion cell axons grow into the tectum/superior
colliculus (SC) in a mostly nontopographic manner and substan-
tially overshoot their future termination zones (Nakamura and
O’Leary, 1989; Simon and O’Leary, 1992). A rough topographic
map develops through axon branching and arborization at cor-
rect target sites, resulting in the formation of topographically
appropriate but diffuse termination zones. In this process, tem-
poral retinal axons form branches preferentially in the anterior
tectum/SC, whereas nasal retinal axons branch in the posterior
tectum/SC (for review, see McLaughlin and O’Leary, 2005). Sub-
sequent maturation of the map occurs through large-scale elim-
ination of ectopic branches and overshot axon segments, and the
formation of dense termination zones, involving correlated neu-
ronal activity (Ruthazer and Cline, 2004).
It is believed that the initial processes that ultimately lead to
the formation of termination zones are controlled by an interplay
between global branch-promoting activities and local branch-
suppressing activities. The neurotrophin BDNF acting via the
TrkB receptor is a good candidate for providing this growth-
promoting activity. Injection of BDNF into the tectum of Xeno-
pus laevis tadpoles increases the branching and complexity of
retinal axon terminal arbors, whereas application of neutralizing
antibodies to BDNF reduces axon arborization and complexity
(Cohen-Cory and Fraser, 1995). However, neither BDNF in the
tectum/SC nor TrkB in the retina is expressed in a gradient, in-
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dicating that the TrkB/BDNF system can provide permissive but
not topographic guidance/branching information.
In contrast, members of the Eph family are expressed in gra-
dients in the retina and tectum/SC and, with that, provide posi-
tional information with regard to the anteroposterior and dorso-
ventral axes. Data from in vitro and in vivo experiments indicate
that the Eph family might exert its role in retinotectal mapping in
higher vertebrates by controlling axon branching (for review, see
McLaughlin and O’Leary, 2005).
Here we further characterize the “receptor” function of eph-
rinAs, that is, the expression of ephrinAs on retinal axons in a
nasal temporal gradient, and of EphAs in the tectum/SC in an
anterior posterior gradient. Our previous data derived from in
vivo experiments indicated that activation of ephrinAs on retinal
axons by tectally expressed EphA molecules results in a suppres-
sion of branching of nasal axons in the anterior tectum/SC, i.e.,
directing their branching to the posterior tectum/SC (Horn-
berger et al., 1999; Rashid et al., 2005). However, it was not clear
how ephrinAs exert this effect, in particular because they are
glycosylphosphatidylinositol (GPI)-anchored molecules requir-
ing a transmembrane coreceptor for mediating their receptor
function. By using biochemical approaches and various in vitro
assays, we now provide evidence that ephrinAs suppress the
branching of retinal axons by interacting in cis with TrkB.
It has been proposed that molecules involved in axon guid-
ance and branching are used later to participate in synaptogenesis
and synaptic plasticity, that is, molecules that control axon guid-
ance and branching using attractive and repellent mechanisms
mediate at later stages of development the formation, stabiliza-
tion, and elimination of synapses (Klein, 2004; Ciani and Salinas,
2005). In support of this, our study of hippocampal neurons
suggest that an TrkB/ephrinA interaction is involved here not
only in the control of axon branching but also of synaptogenesis.
Materials andMethods
Reagents and antibodies. NGF (2.5S) was purchased from Alomone Labs.
BDNF was purchased from Promega. The antibody anti-rat TrkA was
from Upstate Biotechnology; anti-FLAG antibody was obtained from
Affinity BioReagents or Sigma; anti-phospho-TrkA (Tyr490), anti-
phospho-phospholipase C (PLC) (Tyr783), anti-phospho-p44/p42
mitogen-activated protein (MAP) kinase, and anti-phospho-Akt
(Ser473) antibodies were from Cell Signaling Technology; anti-Akt (C-
20) antibody and anti-TrkB antibody were purchased from Santa Cruz
Biotechnology; and anti--tubulin antibody, goat anti-mouse IgG–HRP
secondary antibody, anti-FLAG Affinity Gel, and Protein A-Sepharose
were from Sigma. The secondary antibody goat anti-rabbit IgG–HRP was
from GE Healthcare. The chemiluminescent substrates for developing
Western blots were SuperSignal West Dura obtained from Pierce and
EZ-ECL from Biological Industries. Laminin and all tissue culture re-
agents were from Invitrogen. Merosin was from Millipore. Recombinant
EphA7–Fc chimera was obtained from R & D Systems.
Cloning of chick TrkBFLAG and deletion constructs. DNA encoding full-
length chick TrkB was obtained by reverse transcription-PCR using chick
tectal cDNA as source. The sequence containing the mature protein (ASC
…. WAV) was cloned into the expression vector CA (containing the
chick -actin promoter, signal peptide, and two FLAG tags). The dele-
tion constructs were obtained by PCR from this original full-length
clone. TrkB1 starts from amino acid 139 (LSD. . . ), TrkB2 from
amino acid 172 (QDI. . . ), and TrkB3 from amino acid 195 (DLP. . . ).
All clones were resequenced in full to verify they contained the original
TrkB sequences. In case of TrkA and TrkC immunoprecipitations, clones
isolated from rat cDNA libraries were used.
Cloning of Robo2–CC2FLAG and CC2FLAG. DNA encoding of Robo2
and of Robo2–CC2 FLAG were cloned intoCA (see above) via PCR using
a plasmid containing human Robo2 (Hivert et al., 2002) as a template.
For Robo2–CC2 FLAG, the second cysteine-rich domain (CC2) of TrkB
[amino acids 139 –194 (LSD….PNC)] was inserted at amino acid posi-
tion 637 of Robo2, i.e., between amino acids ..GDV and LVR. . . This site
is located between the last (fifth) Ig domain and first fibronectin type III
(FNIII) domain of Robo2, which positions the CC2 domain at approxi-
mately the same distance from the plasma membrane as it is in TrkB (two
FNIII domains in Robo2, two Ig domains in TrkB). The resulting plas-
mid was resequenced verifying the original Robo2 and CC2 sequences.
CC2 FLAG comprising the amino acid sequences 139 –194 (see above)
was cloned by PCR into the expression vector CA.
Cell culture and transfection. PC12 cells were obtained from Dr. Brian
B. Rudkin (Lyon, France). This cell line was cultured as described previ-
ously (Egea et al., 2005). For experiments, PC12 cells were seeded in
polyornithine-precoated 100 mm Petri dishes and left to adhere. Plasmid
DNA containing ephrinA5 FLAG was transfected with Lipofectamine 2000
reagent from Invitrogen, following the instructions of the manufacturer.
In transient transfection experiments, cells were incubated for 48 h be-
fore treatment. Cells were serum deprived for 16 h and treated with NGF
(50 ng/ml) for several time intervals, as indicated. Cell monolayer was
washed twice with ice-cold PBS, and cells were lysed in either SDS lysis
buffer (2% SDS and 125 mM Tris-HCl, pH 6.8) to obtain total cell lysates
or in a modified NP-40 lysis buffer when immunoprecipitation experi-
ments were performed (see below for details). For the generation of
stably expressing cells, the transfection was performed in 60 mm Petri
dishes, and, 2 d later, cells were spitted and diluted (1:2 to 1:10) and
selected using geneticin (G418) at 500 g/ml. After 3– 4 weeks of selec-
tion, the resistant clones were picked up individually and allowed to grow
until they were tested for ephrinA5 FLAG expression by Western blot. For
generating pools of stably transformed PC12 cells, 3– 4 weeks after selec-
tion, the resistant clones were pooled and allowed to grow until they were
tested for ephrinA5 FLAG expression by Western blot.
Immunoprecipitation and Western blot. PC12 transfected cells were
treated with NGF for several time intervals and were lysed in a modified
NP-40 lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM
MgCl2, 10% glycerol, 1 mM sodium orthovanadate, 25 mM NaF, 40 mM
-glycerophosphate, 1% Triton X-100, and 1 EDTA-free Complete
Protease inhibitor cocktail). After cell lysate clearing by centrifugation,
protein was quantified from the supernatant by the Bio-Rad DC Protein
assay kit. Approximately 1 mg of total protein from each sample was
incubated with 100 l of anti-FLAG M2 Affinity gel overnight at 4°C on
an orbital shaker. Immunocomplexes were washed three times with lysis
buffer, suspended in 20 l of Laemli’s buffer, boiled, and loaded onto a
10% SDS-polyacrylamide gel. After gel electrophoresis and protein
transfer to polyvinylidene difluoride membranes, blots were immunode-
tected with anti-rat TrkA antibodies (1:1000) and developed with EZ-
ECL. Membranes were stripped and reprobed with anti-FLAG antibody
to check for equal immunoprecipitation efficiency. Western blot from
total cell lysates was performed as described above, with 40 g of total
protein per sample. Blots were immunodetected with anti-phospho-Akt
(Ser473), anti-phospho-p44/42 MAP kinase (Thr202/Tyr204), anti-
phospho-TrkA (Y490), anti-phospho-PLC, anti-Akt (C-20), anti-rat
TrkA, or anti--tubulin. When necessary stripping of membranes was
performed between immunodetections with 100 mM
-mercaptoethanol, 63.5 mM Tris-HCl, pH 6.8, and 2% SDS, for 30 min
at 50°C. Membranes were developed with EZ-ECL or SuperSignal West
Dura, depending on the primary antibody used, and exposed to Fuji
Super RX films. Densitometric analysis of films was performed with the
Scion Image free software (Meyer Instruments).
Immunoprecipitations of TrkA, TrkB, TrkC, PDGF receptor, and
TrkB deletions were performed as described by Carvalho et al. (2006).
Axon outgrowth and stripe assay. Single cells were prepared from the
nasal third of embryonic day 8 (E8) chick retinas and electroporated with
an enhanced green fluorescent protein (eGFP) expression construct to
facilitate a later analysis of neurite outgrowth essentially as described by
Carvalho et al. (2006), except cultures were plated on laminin-coated (10
g/ml) and merosin-coated (2 g/ml) dishes and cultured for 4 d in
Neurobasal media with 2% B27 supplement, 1 mM glutamine, 5 M
forskolin, and 1% penicillin/streptomycin solution. Use of forskolin re-
sults in an increase in cAMP levels in retinal axons, which correlates with
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an enhanced long-term survival via an in-
creased surface localization of TrkB (Meyer-
Franke et al., 1995, 1998). Retinal ganglion cells
(RGCs) were identified by staining for markers
expressed on retinal axons such as TrkB, Brn3A,
and Thy-I (Sheppard et al., 1991; Xiang et al.,
1995; Garner et al., 1996). Routinely, those
cells/axons with the longest axons were positive
for these markers.
For the stripe assay, cells were plated on a sub-
strate of alternating lanes of EphA7–Fc and Fc, or,
as a control, Fc versus Fc. Protocols are described
previously by Rashid et al. (2005) and Kno¨ll et al.
(2001a). One type of stripe in each setup was la-
beled by the addition of Fc–cyanine 3. Matrices
generating 50-m-wide stripes were used.
Cloning of RNA interference for knockdown of
TrkB. Target sequences for RNA interference
(RNAi) against TrkB were chosen according to
Das et al. (2006). Target sequences for TrkB
RNAi-1 were CTGTGAAATTATGTGGAT-
TAA, for RNAi-3 were AGTCTGAATA-
CATCTGTACTA, and for RNAi-4 were CGC-
CACAATATTGTTCTCAAA. Sequence for




Organotypic slice cultures. Entorhinohip-
pocampal slice cultures were prepared from new-
born ephrinA5/ mice and control littermates,
as well as OF-1 mice (Iffa Credo) as described pre-
viously (Del Río et al., 1997). Mice were anesthe-
tized by hypothermia, their brains were removed,
and the hippocampal formations were dissected
out. Horizontal sections (350m thick) were ob-
tained using a McIlwain tissue chopper. Selected
slices were cultured using the interphase mem-
brane method (Stoppini et al., 1991). A total of
eight entorhinohippocampal cultures per condi-
tion were prepared from each animal type.
One microliter of the following solutions was
applied on top of each slice at 4, 6, 8, and 11 d in
vitro (DIV) after exchange of the medium. For
the experiments performed with ephrinA5/
mice and littermates, slices were treated with 1
l of 0.1% BSA in 0.1 M phosphate buffer (PB)
as controls or 1 l of recombinant human
BDNF (20 ng/l; Millipore Bioscience Research
Reagents). In the experiments using OF-1 mice, organotypic slices were
treated with 0.1% BSA in 0.1 M PB or Fc fragment (5 g/ml) in PB–BSA
as controls and with recombinant mouse EphA7–Fc chimera (5g/ml; R
& D Systems) or recombinant human BDNF (20 ng/l; Millipore Bio-
science Research Reagents) in PB–BSA or with both solutions together.
Electron microscopy. After pharmacological treatments, 13 DIV cultures
were fixed with 2% glutaraldehyde–2% paraformaldehyde in 0.1 M phos-
phate buffer, postfixed with 2% osmium tetroxide, and embedded in
Araldite. Ultrathin sections were collected on Formvar-coated slot grids and
stained with uranyl acetate and lead citrate. Electron micrographs covering
64m2 (final magnification, 20,000) were randomly taken from the stra-
tum radiatum, and the number of synaptic contacts was counted (n 
40–45 micrographs for group; two to three organotypic slice cultures per
condition). Statistical analysis was performed using Student’s t test.
Results
EphrinA activation abolishes BDNF-promoted branching of
retinal axons
We analyzed the effects of an interaction between ephrinAs and
TrkB on the branching of retinal axons in a simple axon out-
growth assay. Single cells were prepared from the nasal third of E8
chick retinas, which contain high amounts of ephrinAs (Horn-
berger et al., 1999), and electroporated with an eGFP expression
plasmid to facilitate subsequent analysis of neurite outgrowth
and branching (Fig. 1). The electroporated cells were plated at
low density on laminin/merosin-coated dishes and were cultured
for the next 4 d. RGCs and their axons were identified by staining
for markers expressed on retinal axons such as TrkB, Brn3A, and
Thy-I (Sheppard et al., 1991; Xiang et al., 1995; Garner et al.,
1996). Cells with the longest axons stained positive for these
markers. The branching of retinal axons was promoted by adding
5 ng/ml BDNF after 1 and 3 d in vitro. The branching of retinal
axons in these cultures thus followed a similar timeframe as in
vivo; branching in the tectum starts from approximately E10 on-
ward (Mey and Thanos, 1992).
To study the effects of an ephrinA activation on BDNF-
promoted branching, EphA7–Fc was bath applied to the cultures
at various concentrations after 2 d, and the number of branches
Figure 1. EphA7–Fc abolishes in a concentration-dependent manner BDNF-promoted branching of retinal axons. Single cells
were prepared fromnasal thirds of E8 chick retinas, electroporatedwith an eGFP expression plasmid to facilitate a later analysis of
neurite outgrowth and branching, and plated at low density on laminin/merosin-coated dishes. After 4 d in culture, typical
branching patterns have emerged. A, Little branching without BDNF. B, Strong branching in the presence of 5 ng/ml BDNF and 1
g/ml Fc. C, Strong reduction in branching after application of 5 ng/ml BDNF and 0.5g/ml EphA7–Fc. Scale bar, 10m. D, A
quantification of branching from three independently performed experiments with each n 15. E, The lengths of the axons in
various EphA7–Fc concentrations were not affected. Statistical analysis was performed using ANOVA. F, Overexpression of eph-
rinA5 on retinal axons results in an increase in branching, which can be further enhanced by treatment with BDNF. Statistical
analysiswas performedusingANOVAwithDunnett’spost hoc test.G, The increase in branching causedbyBDNF, on top of a higher
branching caused by amoderate overexpression of ephrinA5, can be abolished by treatment with EphA7–Fc (1g/ml), whereas
treatmentwith EphA7–Fc in the absence of BDNFhas no effect on branching. Analyseswere doneby one-wayANOVAand Tukey’s
multiple-comparison test.
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per axon was determined after an additional 2 d in culture. Be-
cause of low-density plating, it was possible unambiguously to
analyze branches emerging from individual axons, thus avoiding
the inclusion of “branches” resulting from defasciculation events.
Only branches 5 m in length were included in the analysis
(Simon and O’Leary, 1992). We observed that EphA7–Fc re-
duced, in a concentration-dependent manner, the number of
branches on retinal axons (Fig. 1A–D), without having an effect
on axon length (Fig. 1E). Application of control Fc had no mea-
surable effect on either branch number or axon length. In con-
trast, in the absence of BDNF, application of EphA7–Fc did not
affect the number of branches (data not shown). Thus, ephrinA
activation suppresses the BDNF-dependent increase in axonal
branching in a concentration-dependent manner.
Increasing the level of expression of ephrinA5 in nasal retinal
axons via electroporation of an ephrinA5 expression construct
led to a strong increase in the branching of retinal axons com-
pared with retinal axons electroporated with the parental (con-
trol) plasmid (Fig. 1F,G), indicating a direct correlation between
the level of expression of ephrinAs and RGC axon branching.
Neurons that overexpressed ephrinA5 and were then exposed to
BDNF showed an additional enhancement of branching (Fig.
1F,G). The increase in branching caused by moderate overex-
pression of ephrinA5 in the presence of BDNF could be abolished
by application of EphA7–Fc, whereas EphA7–Fc application to
ephrinA-overexpressing axons in the absence of BDNF had no
effect on branching (Fig. 1G).
The increase in branching mediated by ephrinA5 overexpres-
sion is at least in part dependent on TrkB, because this increased
branching can be diminished by coexpression of TrkB RNAi (Fig.
2C). The RNAi used were shown in parallel experiments to down-
regulate TrkB protein expression (Fig. 2A) and to abolish the
increase in branching of RGCs after application of BDNF (Fig.
2B).
EphA7–Fc suppresses branching of retinal axons in the
stripe assay
Is the suppression of branching by ephrinA activation a global
effect through, for example, spreading of the signal along the
entire axon, or is it a local effect confined to those axon regions in
which ephrinAs are activated?
To distinguish between these mechanisms, we used the stripe
assay technique (Fig. 3) (Walter et al., 1987; Hornberger et al.,
1999) and generated alternating lanes of EphA7–Fc and Fc pro-
tein, mimicking, in a very basic way, anterior and posterior tec-
tum, respectively. After electroporation with eGFP, single cells
from E8 chick retinas were plated onto this substrate and incu-
bated for 4 d in the presence of BDNF to promote branching of
retinal axons. At high concentrations of EphA7–Fc and Fc (30
g/ml each), retinal cell bodies were found preferentially on Fc
stripes, and outgrowing axons showed a preference for Fc lanes,
indicating a repulsion from EphA7–Fc-containing stripes, as de-
scribed previously (Rashid et al., 2005).
However, when the concentration of EphA7–Fc and Fc was
decreased to 10 g/ml each, cell bodies were found randomly on
both types of stripes, and axons grew indiscriminately over both
types of stripes. At these concentrations, therefore, EphA7–Fc is
no longer repellent for axonal growth cones. We observed, how-
ever, that, under these conditions, retinal axons developed
branches preferentially on Fc stripes, with little or no branching
occurring on EphA7–Fc stripes (Fig. 3A). In control stripe assays
with both lanes containing only Fc protein, there was no prefer-
ence for branching on either stripe (Fig. 3B). Axon length was
comparable on both types of stripes (EphA7–Fc/Fc and Fc/Fc;
data not shown).
A quantification of three independently performed experi-
ments showed for EphA7–Fc versus Fc stripes 1.21 branches per
axon on EphA7–Fc stripes compared with 3.11 branches per axon
on Fc stripes (***p 0.001, Student’s t test), whereas in parallel
experiments with Fc versus Fc stripes, there were 4.51 branches
per axon on the first generated stripe and 4.8 branches per axon
on the second stripe (difference in branch numbers not signifi-
Figure 2. Downregulation of ephrinA5-evoked increase in retinal axon branching via RNAi-
mediated knockdown of TrkB.A, CHO cells were transfectedwith TrkB FLAG alone,with TrkB FLAG
and the empty RNAi vector, or with one of three different RNAi specific for TrkB. Lysates were
analyzed the following day for TrkB expression levels, which were normalized by blotting with
an -tubulin antibody. All three RNAi let to a significant downregulation of TrkB expression.
RNAi with point mutations in the TrkB targeting sequence (e.g., RNAi-4**; see Materials and
Methods) had no effect on TrkB expression level (right). B, Abolishment of BDNF-mediated
increase in retinal axonbranchingbyexpressionof threedifferent TrkBRNAi. The summary from
three independent experiments is shown. Statistical analysis was performed using one-way
ANOVA with Tukey’s multiple-comparison test. C, The increase in branching mediated by eph-
rinA5 overexpression (see also Fig. 1) and its further increase by BDNF application can be dimin-
ished by overexpression of TrkB RNAi. The downregulation of branching is not complete, indi-
cating that the knockdown of TrkB is not complete or that other molecules are involved in
mediating the effect of ephrinA5 overexpression on branching. A reduction in branching is
apparent also in the absence of BDNF, suggesting that overexpression of ephrinA5 results in a
ligand-independent TrkB/ephrinA5 interaction. The summary from three independent experi-
ments is shown. Statistical analysis was performed using one-way ANOVA with Tukey’s
multiple-comparison test. *p 0.05; **p 0.01; ***p 0.001.
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cant, Student’s t test). A total of 71 axons
for the Eph–Fc versus Fs stripe assays and
48 axons for the Fc versus Fc stripe assays
were analyzed for the three independent
experiments.
These data indicate that, at lower con-
centrations, EphA7–Fc exerts a branch-
suppressing activity on retinal axons and a
repellent effect on growth cone guidance
only at higher concentrations. The data
also suggest that, in this case, BDNF-
promoted global branching can be sup-
pressed locally, e.g., topographically, by
EphA7–Fc via ephrinA reverse signaling.
Thus, the branch suppression observed is a
local phenomenon and is restricted to
those sections of the axons in which ephri-
nAs are activated. Therefore, it is possible
to reproduce in this in vitro assay the topo-
graphically specific branching seen in vivo,
in which nasal retinal axons are prevented
from branching in the anterior SC/tectum
expressing higher amounts of EphAs (see
Fig. 8B).
EphrinA5 and ephrinA6 interact with all three Trks
The local and concentration-dependent suppression of BDNF-
induced branching by EphA7–Fc seen in the outgrowth and
stripe assay raises the possibility that ephrinA5 and Trks either
share downstream signaling pathways and/or that they directly
interact at the membrane. To investigate this second possibility,
we expressed full-length TrkA, TrkB, or TrkC together with
FLAG-tagged ephrinA5 (ephrinA5 FLAG) in CHO cells. Lysates
from transfected cells were immunoprecipitated using anFLAG
antibody, and the precipitates were then analyzed by Western
blotting for the presence of the Trk proteins. We found that all
three Trk receptors coimmunoprecipitated with ephrinA5 FLAG
(Fig. 4A) (supplemental Fig. 1, available at www.jneurosci.org as
supplemental material), as well as with ephrinA6 FLAG (supple-
mental Fig. 2, available at www.jneurosci.org as supplemental
material), which is also prominently expressed in the chick retinal
ganglion cell layer (Menzel et al., 2001). It has to be kept in mind
that transient transfection of Trks results under standard condi-
tions in activated/phosphorylated Trk receptors (but see Fig. 5).
In contrast, the PDGF receptor, another receptor tyrosine kinase,
did not interact with ephrinA5 HA (Fig. 4B) (Carvalho et al.,
2006).
EphrinA5 and TrkB interact via CC2
We then aimed to identify the part of TrkB that mediates the
interaction with ephrinA5. A preliminary deletion analysis of rat
TrkA (data not shown) led us to focus on CC2 (Perez et al., 1995).
This domain is flanked N terminally by leucine-rich domains and
on the C-terminal side by the two Ig domains comprising the
neurotrophin binding site (Fig. 4C). The CC2 domain is highly
conserved between TrkA, TrkB, and TrkC. We generated and
analyzed FLAG-tagged versions of chick TrkB with a deletion
from the NH2 terminus up to the CC2 domain (TrkB1
FLAG)
(Fig. 4C), a deletion including part of CC2 (TrkB2 FLAG), and a
deletion including the entire CC2 domain (TrkB3 FLAG). Thus,
the difference between TrkB1 FLAG and TrkB3 FLAG is the pres-
ence or absence of the 55 amino acid long CC2 domain. There
was no obvious difference in expression level and transport to the
cell surface of all three deletion constructs compared with full-
length TrkB (supplemental Fig. 3, available at www.jneurosci.org
as supplemental material) (data not shown).
Coimmunoprecipitation experiments in CHO cells showed
that TrkB1 FLAG, but not TrkB3 FLAG, interacted with
ephrinA5 HA, although there was still some residual binding of
TrkB2 FLAG to ephrinA5 HA (Fig. 4D). These differential inter-
actions were observed using either the anti-HA or the anti-FLAG
antibody for immunoprecipitations, that is, ephrinA5 HA precip-
itates contained TrkB1 FLAG but little or no TrkB2 FLAG or
TrkB3 FLAG. In turn, TrkB1 FLAG precipitates contained
ephrinA5 HA, but little ephrinA5 HA was detected in TrkB2 FLAG
precipitates and no ephrinA5 HA was present in TrkB3 FLAG pre-
cipitates (data not shown). Comparable data using similar con-
structs were obtained for HEK293 cells (data not shown).
Next, we cloned the CC2 domain into Robo2 FLAG, which nor-
mally does not interact (i.e., in coimmunoprecipitations) with
ephrinA5 HA (Fig. 4E). The CC2 domain was cloned between the
fifth Ig domain and the first fibronectin type III domain (Fig. 4C)
(see Materials and Methods), resulting in a chimeric Robo2–
CC2 FLAG protein, in which the distance between the CC2 domain
and the plasma membrane is similar to that in TrkB. We found
that Robo2–CC2 FLAG also coimmunoprecipitates with
ephrinA5 HA (Fig. 4E). This demonstrates that the CC2 domain is
not only necessary but also sufficient for the TrkB/ephrinA5
interaction.
Expression of an isolated CC2 domain in RGCs abolishes the
BDNF-mediated increase in retinal axon branching
We analyzed the effects of expressing in RGCs an isolated CC2
domain (CC2 FLAG) on the ephrinA/Trk interaction, anticipating
that the CC2 domain would abolish the ephrinA/Trk interaction
by acting as a “dominant negative.” In control experiments, we
found that a fraction of CC2 FLAG is secreted into the medium
from transfected CHO cells, from which it could be immunopre-
cipitated (supplemental Fig. 4A, available at www.jneurosci.org
as supplemental material), whereas another fraction was bound
to the cell membrane or was detected in CHO cell lysates (sup-
plemental Fig. 4B,available at www.jneurosci.org as supplemen-
tal material).
Figure 3. Local abolition of BDNF-promoted branching by EphA7–Fc in the stripe assay. Substrates containing alternating
lanes of EphA7–Fc versus Fc (A) or Fc versus Fc (B)were prepared according to standard procedures (Hornberger et al., 1999; Kno¨ll
et al., 2001a) and overlaid with laminin/merosin. Then single retinal cells from the nasal third of E8 retinas were plated onto this
carpet and incubated for 4 d in the presence of 20 ng/ml BDNF. A, On an EphA7–Fc versus Fc substrate, primary axon growthwas
not affected, but axons showedabias against branchingonEphA7–Fc containing stripes. Stripes labeled in red contain EphA7–Fc.
B, On a control substrate containing Fc versus Fc lanes, axons showed no bias in their branching behavior. For a quantification of
these data, see details given in Results. Scale bar, 10m.
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We then expressed CC2 FLAG in RGCs
to study its effect on branching in the axon
outgrowth assay. We found that CC2 FLAG
expression abolishes the increase in
BDNF-mediated branching, whereas ec-
topic expression of control proteins such
as eGFP had no effect on branching (Fig.
4F). Likewise, the increase in branching
after ephrinA5 overexpression is dimin-
ished by CC2 expression (Fig. 4G).
These data suggest that TrkB interacts
with ephrinA5 on retinal ganglion cell ax-
ons via its CC2 domain. The formation of
a complex between these molecules pro-
motes retinal axon branching, whereas an
abolishment of this interaction via expres-
sion of a soluble CC2FLAG domain abrogates
the BDNF-dependent increase in branching.
Neurotrophin-inducible interaction
between TrkA and ephrinA5
Next we investigated whether the interac-
tion between Trks and ephrinAs is induc-
ible by neurotrophins. We found that
transient transfection of Trks resulted un-
der standard conditions in activated/phos-
phorylated Trk receptors making such an
approach unsuitable (data not shown).
We therefore used PC12 cells, which endo-
genously express TrkA and in which the
basal levels of tyrosine phosphorylation
and activation of TrkA are low but can be
induced by NGF treatment (Hempstead et
al., 1992).
After transfection of ephrinA5 FLAG,
PC12 cells were treated with 50 ng/ml
NGF for various time intervals (Fig. 5).
The interaction between TrkA and
ephrinA5 FLAG was observed by immuno-
precipitation of ephrinA5 FLAG from ly-
sates of transfected cells using an anti-
Figure 4. The CC2 domain of TrkB mediates the interaction with ephrinA5. Coimmunoprecipitation experiments with cell
lysates from CHO cells, 1–2 d after transient transfection with expression constructs as specified below. A, Cotransfection of
ephrinA5 FLAGwith either TrkA, TrkB, or TrkC and subsequent immunoprecipitation of lysates using anFLAG antibody resulted in
a coimmunoprecipitation of all three Trks with ephrinA5 FLAG. The left shows analysis of the input that is a fraction of the CHO cell
lysate before addition of the precipitating antibody. The right shows the analysis of immunoprecipitates (IP) using the FLAG
antibody. TheTrk receptorsweredetectedusingpan-Trk antibodyandephrinA5 FLAGusing the sameFLAGantibodyasused for
the coimmunoprecipitation. IB, Immunoblot. B, Under the same conditions, the FLAG-tagged PDGF receptor does not coimmu-
noprecipitate with ephrinA5 HA (Carvalho et al., 2006). C, Schematic representation of the domain structure of TrkB and of TrkB
deletion mutants focusing on the CC2 domain (CC, conserved cysteine; L, leucine-rich repeats; Ig, Ig domains; K, kinase domain).
To the right, the domain structure of Robo2 FLAG and of Robo2-CC2 FLAG is schematized. The arrow indicates the positionwhere the
CC2domainwas inserted.D, The analysis of TrkB FLAG deletion constructs (TrkB1 FLAG TrkB3 FLAG) in coimmunoprecipitation
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experiments with ephrinA5 HA using an HA-antibody
showed that the CC2 domain is necessary for the TrkB FLAG/
ephrinA5 HA interaction. This selective interaction is observed
also if using the FLAG antibody (to precipitate TrkB pro-
teins) for immunoprecipitations (data not shown). E, Robo2–
CC2 FLAG, but not Robo2 FLAG, coimmunoprecipitates with
ephrinA5 HA, indicating that the CC2 domain is sufficient for
the interaction with ephrinA5 HA. F, Expression of an isolated
CC2 FLAG domain in RGCs resulted in an abolishment of the
increase in BDNF-induced branching in the axon outgrowth
assay, whereas expression of CC2 FLAG and omission of BDNF
treatment had no effect on branching. Overexpression of
eGFP was used in control experiments. The summary of re-
sults from three independently performed experiments is
shown. Statistical analysis was performed using one-way
ANOVA with Tukey’s multiple-comparison test. G, The in-
crease in branching caused by overexpression of ephrinA5 in
RGCs (Fig. 1 F) in the axon outgrowth assay can be abolished
by expression of the CC2 FLAG domain. Statistical analysis was
performed using one-way ANOVA with Tukey’s multiple-
comparison test. *p 0.05; ***p 0.001.
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FLAG antibody. We found that, in the absence of NGF, TrkA was
not detected in ephrinA5 FLAG precipitates, indicating a lack of
interaction between nonactivated TrkAs and ephrinA5 FLAG.
NGF treatment, however, led to the coimmunoprecipitation of
TrkA and ephrinA5FLAG (Fig. 5A). This interaction was observed
from 30 min up to 120 min after NGF application. Total cell lysates
from the same samples were immunoblotted with anti-phospho-
Akt and anti-phospho-Erk1/2 antibodies to verify NGF-induced ac-
tivation of signaling cascades (Fig. 5B).
EphrinA5 binding to Trk specifically augments Akt activation
Subsequently, we analyzed which of the signaling pathways of
activated Trk receptors were affected through its interaction with
ephrinA5 (Fig. 6) (supplemental Fig. 5, available at www.
jneurosci.org as supplemental material). For this, a PC12 cell
clone stably expressing ephrinA5 FLAG was analyzed in parallel to
a control PC12 cell clone (i.e., stably transfected with the parental
vector only). We established the level and duration of activation
of the main signaling pathways of Trks, that is, the PI-3 kinase,
the PLC, and the MAP kinase pathways (Segal, 2003), by inves-
tigating the phosphorylation level of Akt, PLC, and Erk1/2, re-
spectively. In the control PC12 cell line, application of NGF led to
a rapid and sustained activation of all three pathways (Fig. 6A,B).
For the ephrinA5-expressing cell line, however, the PI-3 kinase
pathway upregulation was significantly stronger than in the con-
trol cell line, whereas a similar activation compared with the
control cell line was seen for the MAP kinase and PLC pathways
(Fig. 6A,B). Similar data were also obtained using pools of PC12
cell clones stably expressing ephrinA5 (supplemental Fig. 5, avail-
able at www.jneurosci.org as supplemental material). In turn,
application of EphA7–Fc led to a downregulation of pAkt signal-
ing (Fig. 6C). A densitometric quantification of Akt phosphory-
lation in the presence or absence of EphA7–Fc showed that, 5 min
after NGF treatment, phospho-Akt levels were down to 83.8 
15.1% (mean SEM) and to 39.3 9.8% (mean SEM) after
30 min of NGF treatment (statistical analysis was performed by
Student’s t test, *p 0.05).
Given the correlation between PI-3 kinase signaling and axon
branching (Gallo and Letourneau, 1998; Markus et al., 2002),
these data fit well with the increased branching of retinal axons
after augmented expression of ephrinA5 in RGCs (see above).
TrkB/ephrinA interactions control synaptic plasticity in
the hippocampus
There is mounting evidence that molecules controlling axon
guidance and branching are also important in synaptogenesis and
synaptic plasticity at later stages of development. Thus, we were
interested whether an ephrinA/TrkB interaction is involved also
in these later occurring processes. For this purpose, we turned to
the hippocampal system in which recent investigations have
shown that ephrinAs/EphAs are involved in the control of synap-
togenesis (W. Q. Gao et al., 1998; Murai et al., 2003; Martínez et
al., 2005; Martínez and Soriano, 2005; Otal et al., 2006). In addi-
tion, the TrkB/BDNF system plays here a pivotal role in synapse
formation (Martínez et al., 1998; Pozzo-Miller et al., 1999).
In agreement with previous studies (Martínez et al., 1998;
Stein et al., 1999), RNA in situ hybridization showed that neurons
in the pyramidal layer of CA1–CA3 regions coexpress ephrinA5
and TrkB transcripts at birth (postnatal day 0) (supplemental Fig.
6, available at www.jneurosci.org as supplemental material), as
well as at postnatal stages (postnatal days 5–21; data not shown).
Furthermore, cultured hippocampal neurons were immunopo-
sitive for ephrinA and TrkB protein expression (Fig. 7A–C). Con-
focal analysis revealed the colocalization of these proteins on ax-
ons, with a particularly strong expression on growth cones (Fig.
7C). Thus, these data suggest that ephrinA5 and TrkB are coex-
pressed on CA1–CA3 pyramidal axons and growth cones at a
time when they invade the target termination layers and form
synapses.
To investigate the interactions of BDNF and ephrinA in syn-
aptogenesis, we used long-term organotypic slice cultures, and
the number of synaptic contacts was determined using electron
microscopy. Our analysis focused on the CA1 stratum radiatum,
which receives associational axonal input from CA3 pyramidal
neurons. For these experiments, entorhinohippocampal slice
cultures were prepared from newborn wild-type and eph-
rinA5/ mice. After frequent application of BDNF over the fol-
lowing days (see Materials and Methods), the cultures were fixed
after 13 d in vitro, and the number of synaptic contacts in the
stratum radiatum was determined using electron microscopy. As
expected, BDNF treatment led to an increase in synaptic density
in wild-type mice. However, the increase was significantly re-
duced in ephrinA5 mutant mice (Fig. 7H). The BDNF-mediated
increase in synaptic density in ephrinA5/mice when compared
with controls without BDNF treatment suggests that the BDNF-
mediated increase in synaptogenesis in the stratum radiatum is to
some extent ephrinA5 independent, one possibility being that it is
compensated by other ephrinAs.
We then studied the effects of EphA7–Fc on BDNF-mediated
synaptogenesis in wild-type mice. EphA7–Fc affects the entire
EphA system, because it binds not only ephrinA5 but almost all
ephrinAs. Incubation with BDNF resulted in a 42% increase in
the number of synaptic contacts in the stratum radiatum, which
was significantly reduced when slices were coincubated with
EphA7–Fc (Fig. 7I). We found that treatment with BSA, Fc, or
EphA7–Fc without BDNF had no significant effect on the density
of synaptic contacts (Fig. 7I).
These synaptogenesis data bear a close similarity to the effects
of EphA7–Fc and BDNF on branching of RGC axons (Fig. 1). We
therefore investigated whether branching of hippocampal neu-
rons was affected by these molecules in a similar way to that of
Figure 5. TrkA coprecipitates with ephrinA5 FLAG in PC12 cells after NGF stimulation. PC12
cells transiently transfected with ephrinA5 FLAG or with phosphorylated enhanced yellow fluo-
rescent protein (eYFP) (as a control of transfection efficiency) were treated with 50 ng/ml NGF
for several time intervals.A, After immunoprecipitationof ephrinA5 FLAG, thepresenceof TrkA in
the precipitates was analyzed by Western blot, and the precipitation of ephrinA5 was verified.
IB, Immunoblot; IP, immunoprecipitation.B, Total cell lysates from the same samples were run
to check NGF-induced activation of signaling cascades with anti-phospho-Akt and anti-phos-
pho-Erk1/2 antibodies, and, aftermembrane stripping, protein loadingwas checkedwith anti-
tubulin (bottom panels) antibodies.
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RGC axons. For this purpose, hippocam-
pal neurons from E18 rat embryos were
transfected with an eGFP expression con-
struct to facilitate later analysis of branch-
ing, plated on laminin-coated dishes, and
treated in the following days with BDNF
and/or EphA7–Fc using a protocol similar
to that of retinal cultures. Strikingly, here
again BDNF application let to an increase
in axon branching that could be abolished
by EphA7–Fc (Fig. 7J). Application of
EphA7–Fc in the absence of BDNF did not
lead to a reduction in branching (Fig. 7J).
These data indicate that the same molecu-
lar players are involved in the control of
axon branching and synaptogenesis of
hippocampal neurons.
Discussion
In this work, we have characterized a novel
cis interaction between ephrinA5 and
TrkB on RGC axons. Our data suggest that
this interaction contributes to the control
of axon branching during development of
the retinotectal projection and is also in-
volved in branching and synaptogenesis of
hippocampal neurons.
EphrinA/TrkB interactions on RGCs
control axon branching
We have shown recently that ephrinA-
expressing retinal axons are repelled from
growing on stripes containing EphA7–Fc
when given the choice between EphA7–Fc
and Fc lanes (Rashid et al., 2005). We have
here now investigated whether ephrinA
activation by EphA7–Fc would also sup-
press the BDNF-promoted branching of
retinal axons, because that is the key step
during development of the retinotectal/
collicular projection.
Using lower concentrations of
EphA7–Fc in the stripe assay than those
used by Rashid et al. (2005), we observed
that primary axons were no longer re-
pelled and grew indiscriminately over both
types of stripes. However, now we found a
diminished branching on EphA-
containing stripes compared with control
stripes (Fig. 3). Furthermore, we show that
the degree of suppression of BDNF-
promoted branching is sensitive to the
level of activation of ephrinAs, i.e., the
concentration of EphA7–Fc applied (Fig.
1). Thus, the interaction between TrkB
and ephrinAs has key features of molecules
involved in topographic mapping: con-
centration dependency and spatial
restriction.
In the context of retinocollicular/tectal
mapping, this leads to a model in which
BDNF acts as a global branch-promoting
factor and ephrinAs/EphAs suppress this
Figure 6. EphrinA5 FLAG expression in PC12 cells induces an additional activation of Akt after NGF treatment. A, Time course
experiment to compare the response to NGF of two PC12 clones stably transfected with ephrinA5 FLAG or the empty vector (Neo).
Total cell lysates (40gof protein)were analyzedbyWesternblot to check the status of phosphorylationof TrkAanddownstream
signaling molecules Akt, Erk1/2, and PLC (supplemental Fig. 5, available at www.jneurosci.org as supplemental material). B,
Densitometric analysis of the level of phosphorylation of Akt, Erk1, and Erk2 from four independent experiments. Statistical
analysis was performed by Student’s t test, *p 0.05. C, Effect of EphA7–Fc addition on the activation of signaling cascades by
NGF. Pools of PC12 cells stably expressing ephrinA5 FLAG were pretreated with 1g/ml of EphA7–Fc or left untreated before NGF
(100 ng/ml) addition for the time periods indicated. Total cell lysates were analyzed by Western blot as described in A.
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activity in a local manner, leading to topo-
graphically specific branching. This means
that nasal axons, with higher expression of
ephrinAs than temporal axons, are sup-
pressed from branching in the anterior
tectum/SC, because here high(er) expres-
sion of tectal EphAs activate axonal ephri-
nAs and abolish the BDNF-mediated
branching. As a consequence, nasal axons
branch only in the posterior tectum/SC
(Fig. 8).
Formation of local termination zones
controlled by counter gradients of
ephrinAs and EphAs
Taking into account that competition be-
tween axons is involved in topographic
mapping (Brown et al., 2000), we propose
that individual axons branch at a position
at which the suppression of BDNF-
promoted branching (relative to other ax-
ons) reaches a local minimum (Fig. 8).
Thus, the proximal limit of the developing
termination zone would be defined by ac-
tivation of axonal ephrinAs by EphAs,
which are expressed in an anterior pos-
terior gradient in the tectum/SC.
The formation of confined termination
zones necessitates a counter gradient sys-
tem defining the distal limit of a termina-
tion zone (Fig. 8B). It is plausible that this
system also involves EphA/ephrinAs, al-
though in this case, axonal EphAs, locally
activated by a tectal anterior  posterior
gradient of ephrinAs, confine global Trk-
mediated branching. Interestingly, Ephs
and Trks share a common downstream
adaptor molecule, ARMS (ankyrin repeat-
rich membrane spanning protein) (Kong
et al., 2001), which is expressed widely
throughout the developing nervous sys-
tem and represents an interesting candi-
Figure 7. EphrinA5 cooperates in BDNF-induced synaptogenesis in hippocampal neurons. A–C, Double-labeling confocal
images showing two examples of axonal growth cones (arrows) from hippocampal explants after 4 d in culture. Axonal growth
cones coexpress TrkB (viewed by Alexa488-labeled antibody; A) and ephrinAs (using EphA7–Fc and viewed by Texas Red; B) as
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displayed in merged images (C). D–G, Electron micrographs
illustrating axon terminals and synaptic contacts (arrows) in
the stratum radiatum of organotypic cultures fromwild-type
and ephrinA5/ mice under control conditions (D and F,
respectively) and after treatmentwith BDNF (E andG, respec-
tively). H, Density of synaptic contacts in the stratum radia-
tum of control and treated organotypic cultures from eph-
rinA5/ mice and their littermates. I, Histogram showing
density of synaptic contacts in the stratum radiatumof 13 d in
vitro organotypic cultures under control conditions (BSA) or
treatment with Fc, EphA7–Fc, recombinant human BDNF
(BDNF), and recombinant human BDNF plus EphA7–Fc
(BDNFEphA7–Fc). Mean  SEM; n.sig, nonsignificant;
**p 0.01, Student’s t test; ***p 0.001. at, Axon termi-
nal; s, dendritic spine. Scale bars:A–C, 10m;D–G, 0.5m.
J, EphA7–Fc treatment abolishes the BDNF-induced branch-
ing of hippocampal neurons. Using a protocol described in
experiments documented in Figure 1, hippocampal neurons
were treated for 2 d under various conditions as indicated.
12708 • J. Neurosci., November 26, 2008 • 28(48):12700–12712 Marler et al. • TrkB/EphrinA Interaction
date as an integrator of Trk/Eph-controlled branching (Fitzger-
ald et al., 2008).
The CC2 domain of TrkBmediates the interaction
with ephrinAs
Interestingly, the ephrinA/TrkB interaction has two features: in
the absence of activation of ephrinAs (by EphA molecules), the
BDNF-dependent ephrinA/TrkB interaction promotes axon
branching, whereas ephrinA activation (by EphA7–Fc) results in
a suppression of branching.
We addressed whether it is the interaction between ephrinAs
and TrkB at the cell membrane that controls the level of RGC
axon branching but not, for example, a cross regulation of con-
verging signaling pathways downstream of ephrinAs and TrkB.
The analysis of a deletion series and of chi-
meric proteins led us to identify the CC2
domain in TrkB (Perez et al., 1995) as the
domain necessary and sufficient for its in-
teraction with ephrinA5 (Fig. 4). In partic-
ular, a chimeric protein of Robo2 and the
CC2 domain binds to ephrinA5, whereas
the wild-type form of Robo2 does not. We
then showed that an isolated CC2 domain
can act as a dominant negative (likely as a
result of a disruption of the ephrinA/TrkB
interaction), because the overexpression
of CC2 in retinal axons results in an abol-
ishment of the BDNF-induced increase in
retinal branching. Intriguingly, also the in-
crease in branching caused by overexpres-
sion of ephrinA5 could be blocked by a
simultaneous expression of CC2.
The CC2 overexpression experiments
provide good evidence that it is the inter-
play between ephrinAs and TrkB at the cell
membrane that controls retinal axon
branching.
The CC2 domain together with the
leucine-rich repeats and the NH2-terminal
CC1 domain form the evolutionary most
conserved part between all three Trks
(Benito-Gutie´rrez et al., 2006). This might
explain why ephrinA5 and ephrinA6 (and
possibly other ephrinAs) interact with all
three Trks (Fig. 4) (supplemental Fig. 2,
available at www.jneurosci.org as supple-
mental material). To date, there have been
few other reports on the role of the CC2
domain in Trk function. The neurotro-
phin receptors are, however, known to in-
teract with some other receptor systems
(Chao, 2003).
The ephrinA/Trk interaction further
augments the PI-3 kinase pathway
We found that the Trk/ephrinA5 interac-
tion is induced by neurotrophins (Fig. 5)
and results in a preferential activation of
the PI-3 kinase/Akt pathway (Fig. 6). The
two other main TrkB signaling pathways,
MAP kinase and PLC, were not enhanced
when compared with Trk signaling in the
absence of ephrinAs. In a complementary
set of experiments, we show that treatment of TrkB/ephrinA5-
expressing cells with EphA7–Fc resulted in a decreased phospho-
Akt output (Fig. 6).
Interestingly, other investigations have shown that TrkA-
mediated increase in axon branching occurs specifically via PI-3
kinase and Akt activation (Gallo and Letourneau, 1998; Markus
et al., 2002). In agreement with this, we propose that the eph-
rinA5/TrkB complex controls retinal axon branching via PI-3
kinase signaling. Thus, an increase in ephrinA5 expression leads
to higher PI-3 kinase signaling and an increase in BDNF-
mediated branching, whereas EphA7–Fc treatment (and activa-
tion of ephrinAs) leads to a reduction in PI-3 kinase signaling as
well as a reduction in axon branching (Figs. 6, 8).
A target of PI-3 kinase is GSK3, a central control element in
Figure 8. Model for the topographic branching of retinal axons in the tectum/SC based on an interaction between ephrinAs
and TrkB. A, Schematic expression pattern of EphAs and ephrinAs in the retina (left) and tectum/SC (right). BDNF is uniformly
expressed in the tectum/SC and promotes branching of retinal axons globally via TrkB. The axonal projection pattern is indicated
withnasal axonsprojectingonto theposterior tectum/SCand temporal axonsonto theanterior tectum/SC.B, EphAsandephrinAs,
aswell as TrkB receptors, are uniformly distributed over the entire length of the axon. Local activation of ephrinAs on retinal axons
in the proximal part of the axon and of EphAs in the distal part of the axon, causing a corresponding local suppression of branching
resulting in the formation of a termination zone in that part of the axon in which branch suppression is minimal. Suppression
anterior to the termination zone: ephrinAs are activated locally by tectally expressed EphAs. Activated ephrinAs in turn abolish
BDNF-mediated branching. Because of the anterior posterior gradient of EphAs, branch suppression occurs anterior (proximal)
to the termination zone. Suppression posterior to the termination zone: it appears plausible that this activity is controlled by
gradients of ephrinAs in the posterior tectum/SC (Yates et al., 2001), which activate retinal EphA receptors and which might
interfere with TrkB signaling (Kong et al., 2001; Fitzgerald et al., 2008). C, Effects of ephrin/TrkB interactions on retinal axon
branching. Binding of BDNF to TrkB results in its activation and tyrosine phosphorylation and leads via activation of, in particular, PI-3
kinase signaling to an increase in branching. Interaction of activated TrkB with ephrinAs (possibly in lipid rafts; orange) augments PI-3
kinase signaling andbranching. Activation of ephrinAs by EphAs diminishes branching and a reduction in pAkt signaling.
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regulating cytoskeletal dynamics during axon branching and
guidance (Zhou and Snider, 2005). Axonal expression of a
dominant-negative form of GSK3 disturbs the development of
the retinotectal projection in zebrafish. Here the number of
added branches was decreased, whereas that of eliminated
branches was not changed (Tokuoka et al., 2002). Interestingly,
TrkB signaling also promotes branch addition but not their elim-
ination (Cohen-Cory, 1999). These links strongly implicate that
the PI-3 kinase pathway is the main pathway by which ephrinA5/
TrkB complexes promote branching.
A possible role of membrane microdomains in
TrkB/ephrinA interactions
Binding of BDNF to TrkB results in a shift of TrkB into a special,
lipid raft-like, membrane microenvironment (Bilderback et al.,
1999; C. S. Huang et al., 1999; Guirland et al., 2004; Suzuki et al.,
2004). Signaling from within this special lipid environment is
crucial for at least some TrkB functions, because the pharmaco-
logical disruption of raft-like structures abolishes BDNF-
mediated axon guidance (Guirland et al., 2004). It has been pro-
posed that these lipid microdomains function through their
capacity to promote certain protein–protein interactions but
prevent others, leading to the establishment of a different signal-
ing environment in rafts versus nonrafts (Simons and Toomre,
2001). This kind of regulation appears to be a common phenom-
enon because other receptor tyrosine kinases such as c-Ret also
have been shown to have different signaling properties depen-
dent on their location inside versus outside of raft-like structures
(Tansey et al., 2000; Paratcha et al., 2001).
This concept implies that mechanisms/molecules that shift
TrkB into raft-like structures or promote longer TrkB residence
in this environment will have an impact on the signaling of TrkB.
EphrinAs are GPI-anchored molecules and therefore reside in
rafts (Davy et al., 1999; Huai and Drescher, 2001). Thus, a BDNF-
induced shift of TrkBs into rafts could result in the “capture” of
TrkBs by ephrinAs and lead to an increased residence of TrkB in
these domains. This in turn would affect its signaling, and indeed we
have observed a specific increase in PI-3 kinase signaling (Fig. 5).
Interestingly, the substrate of PI-3 kinase, phosphatidylinositol-4,
5-biphosphate, is particularly enriched in lipid rafts (Golub et al.,
2004); thus, the anticipated increased residence of ephrinA5/
TrkB complexes in rafts correlates well with the augmentation of
this particular signaling pathway.
EphrinA5/Trk interaction in synaptic plasticity
It has been proposed that molecules controlling the guidance and
branching of axons using attractive and repellent mechanisms
might contribute at later stages to the formation, stabilization,
and elimination of synapses as well as the control of synaptic
plasticity. Studies in the retinotectal projection, for example, have
shown that branching and synaptogenesis are closely connected
and interdependent (Meyer and Smith, 2006; Ruthazer et al.,
2006).
On a molecular level, prominent candidates for such dual
roles include members of the Wnt family (Ciani and Salinas,
2005), slits (Campbell et al., 2007), FGFs (Szebenyi et al., 2001;
Umemori et al., 2004), and, in particular, BDNF, which is in-
volved not only in axon branching but also in synaptogenesis,
synapse stabilization, and activity-dependent synaptic plasticity
(Figurov et al., 1996; Martínez et al., 1998; Z. J. Huang et al., 1999;
Alsina et al., 2001; Meyer and Smith, 2006; Ruthazer et al., 2006).
Moreover, although there is ample evidence for a role of the EphB
subfamily in axonal branching and synaptic plasticity, less is
known about that of the EphA subfamily (P. P. Gao et al., 1998;
W. Q. Gao et al., 1998; Murai et al., 2003; Klein, 2004; Martínez et
al., 2005; Martínez and Soriano, 2005; Otal et al., 2006).
However, members of the EphA class are prominently ex-
pressed in regions undergoing synaptogenesis and synaptic plas-
ticity, and ephrinA/EphA members have been shown to be regu-
lated by activity and after lesion (Kno¨ll et al., 2001b; Xu et al.,
2003; Wang et al., 2005; Serizawa et al., 2006). Moreover, ephri-
nAs and neural activity act together to regulate the patterning of
retinocollicular and retinogeniculate connections (Pfeiffen-
berger et al., 2005).
Therefore, we characterized the TrkB/ephrinA interaction in
hippocampal neuronal cultures to investigate axon branching
but used hippocampal organotypic cocultures to study synapto-
genesis (Marty et al., 2000). We could show for both assay systems
that the BDNF-mediated increase in branching or synapse den-
sity could be antagonized by application of EphA7–Fc. Moreover,
the increase in synapse density in ephrinA5 mutant mice was
reduced after BDNF application when compared with wild-type
mice (Fig. 7).
These data correlate very well with our results obtained from
an analysis of branching of RGC axons and suggest that, in addi-
tion to branching, also synaptogenesis in the retinotectal system
is under control of an ephrinA/TrkB interplay.
Overall, our findings support the concept that the same mo-
lecular players, here Trks and ephrinAs, control axon branching
and synaptogenesis/synaptic plasticity in multiple parts of the
brain. An important aspect in the near future will be to determine
more closely the role of neural activity in these interactions.
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